Royal Liverpool and Broadgreen University Hospitals NHS Trust captures the UK’s EHealth Insider (EHI) award for implementing Medworxx Utilisation Management to enable and sustain greater patient flow within its busy hospitals.
TORONTO--(BUSINESS WIRE)-- Medworxx Inc. (“Medworxx”) (TSXV: MWX), a leader in clinical patient flow, compliance and education solutions, is pleased to announce that Royal Liverpool and Broadgreen University Hospitals NHS Trust, has won the national EHI Awards’ category of ‘Outstanding work in IT- enabled change in healthcare’ for the project titled, ‘First UK IT-enabled case management system.’ The Trust is a Medworxx solutions client.
By introducing the Medworxx Utilisation Management and case management system, the first of its kind in UK and Europe, the Trust is focusing on avoiding discharge delays, while maintaining quality patient care. Over the past year, the Trust has reached many milestones of positive change, including a 30% reduction in delayed transfers of care within the first 3 months of implementation.
Trish Armstrong-Child, Director of Operations at Royal Liverpool and Broadgreen University Hospitals is quoted in a post- award interview with EHI Insider: “We are extremely pleased to have won this award. We only set up this project a year ago, and we never expected to come so far, so fast. IT has been an enabler for changing the culture, and it has enabled us to sustain that change.”
The Trust secured the prestigious award, as one of 35 entries for the category. Medworxx Utilisation Management has helped the Trust improve the patient journey, and bridge clinical and operational assessments of appropriate care intensity from admission to discharge.
“It is extremely gratifying that our first UK client has won this distinguished award, and even more fulfilling that the Trust is capturing the benefits our solution has been designed for, in such a short period of time,” said Dan Matlow, President and CEO of Medworxx. “And for this to be recognized in the UK market is very exciting. A special thanks to our consulting partner ModelAdvice DC Consulting for their role in modeling and mentoring during this implementation.”
About Royal Liverpool and Broadgreen University Hospitals NHS Trust
Royal Liverpool and Broadgreen University Hospitals NHS Trust is one of the largest and busiest hospital trusts in the North of England, with an annual budget exceeding £400 million.
It delivers services across two sites and three hospitals, Royal Liverpool University Hospital, Broadgreen Hospital and Liverpool University Dental Hospital and employs more than 5,500 people.
Each year the Trust sees more than half a million people in its outpatient department and deals with around 150,000 emergency patients and day case admissions. It is one of the top teaching trusts in the UK with well-established links to the University of Liverpool, Liverpool John Moores University and international institutions too. In 2013 work will begin on a new £450 million state of the art Royal Liverpool University Hospital.
Medworxx delivers health information technology solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Medworxx Utilisation Management—flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components—currently serves over 30% of the acute care beds in Canada.
Synergies in the Canadian and UK health systems led ModelAdvice DC Consulting and Medworxx to collaborate in addressing the UK market, with a focus on NHS Trust hospitals. ModelAdvice DC methodology for approaching vertical health system integration combines with Medworxx Patient Flow tools to harvest data and intelligence, to model hospitals’ patient flow needs and future requirements.
Founded in 2004, Medworxx Inc. is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: MWX
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.
Julia Zarb, PhD
SVP Marketing & Strategy
T: 1.800.321.1591 | T:416.642.1278 x322
email@example.com | http://uk.medworxx.com/
Peter Ellis, Managing Director
21 Ellis St
London SW1X 9AL
T: +44 (0) 20 7730 9614
President & Chief Executive Officer
T: 1.800.321.1591 | T:416.642.1278 x311
firstname.lastname@example.org | http://uk.medworxx.com/
Source: Medworxx Inc.